Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-040913)

Filing Details

Accession Number:: 0001209191-13-040913
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-08-15 16:42:00
Reporting Period:: 2013-08-15

Filing Date:: 2013-08-15
Accepted Time:: 2013-08-15 16:42:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1182129	Auxilium Pharmaceuticals Inc	AUXL	Pharmaceutical Preparations (2834)	233016883

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1219018	Oliver Fetzer	C/O Auxilium Pharmaceuticals, Inc. 640 Lee Road Chesterbrook PA 19087		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-08-15	169	$18.73	15,928	No	4	S	Direct
Common Stock	Disposition	2013-08-15	500	$18.74	15,428	No	4	S	Direct
Common Stock	Disposition	2013-08-15	300	$18.75	15,128	No	4	S	Direct
Common Stock	Disposition	2013-08-15	500	$18.76	14,628	No	4	S	Direct
Common Stock	Disposition	2013-08-15	200	$18.77	14,428	No	4	S	Direct
Common Stock	Disposition	2013-08-15	200	$18.78	14,228	No	4	S	Direct
Common Stock	Disposition	2013-08-15	31	$18.81	14,197	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Sale of shares made pursuant to reporting person's 10b5(1) Plan, dated May 30, 2013, in order to cover tax liability resulting from the vesting of restricted stock.